APA (7th ed.) Citation

W, K., A, D., W, W., IY, J., CJ, O., M, F., . . . JA, F. (2021). BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia. The Journal of clinical investigation, 131(16), . https://doi.org/10.1172/JCI145459

Chicago Style (17th ed.) Citation

W, Kong, et al. "BET Bromodomain Protein Inhibition Reverses Chimeric Antigen Receptor Extinction and Reinvigorates Exhausted T Cells in Chronic Lymphocytic Leukemia." The Journal of Clinical Investigation 131, no. 16 (2021). https://doi.org/10.1172/JCI145459.

MLA (9th ed.) Citation

W, Kong, et al. "BET Bromodomain Protein Inhibition Reverses Chimeric Antigen Receptor Extinction and Reinvigorates Exhausted T Cells in Chronic Lymphocytic Leukemia." The Journal of Clinical Investigation, vol. 131, no. 16, 2021, https://doi.org/10.1172/JCI145459.